`
`2016 WL 147840
`Only the Westlaw citation is currently available.
`United States Court of Appeals,
`Federal Circuit.
`
`PFIZER INC., Pharmacia & Upjohn
`Company, Pharmacia & Upjohn Company
`LLC, Sugen, Inc., C.P. Pharmaceuticals
`International C.V., Pfizer Pharmaceuticals
`LLC, PF Prism C.V., Plaintiffs–Appellees
`v.
`MYLAN PHARMACEUTICALS
`INC., Defendant–Appellant.
`
`Stanley E. Fisher, Jessamyn Sheli Berniker, Sara Kaiser
`Creighton.
`
`Douglas H. Carsten, Wilson, Sonsini, Goodrich & Rosati,
`PC, San Diego, CA, argued for defendant-appellant. Also
`represented by Peter Soo Kang; Katherine Hasper, Palo Alto,
`CA; Robert Delafield, Austin, TX.
`
`DYK, WALLACH, and HUGHES, Circuit Judges.
`
`JUDGMENT
`
`PER CURIAM.
`
`*1 THIS CAUSE having been heard and considered, it is
`
`No. 2015–1131.
`|
`Jan. 13, 2016.
`
`ORDERED and ADJUDGED:
`
`AFFIRMED. See Fed. Cir. R. 36.
`
`Appeal from the United States District Court for the District
`of Delaware in No. 1:10–cv–00528–GMS, Judge Gregory M.
`Sleet.
`
`All Citations
`
`Attorneys and Law Firms
`
`--- Fed.Appx. ----, 2016 WL 147840 (Mem)
`
`Thomas H.L. Selby, Williams & Connolly LLP, Washington,
`DC, argued for plaintiffs-appellees. Also represented by
`
`End of Document
`
`© 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
` © 2016 Thomson Reuters. No claim to original U.S. Government Works.
`
`1
`
`NOVARTIS EXHIBIT 2087
`Par v Novartis, IPR 2016-00084
`Page 1 of 1